Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
International Journal of Clinical Pharmacy · 2025
DOI: 10.1007/s11096-024-01822-x ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Maria Swartling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Precision Medicine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VINNOVA, Vetenskapsrådet, Uppsala University.
Abstract (Originalsprache)
Background
Current guidelines recommend dosing vancomycin based on the area under the concentration time curve (AUC) to maximise efficacy and minimise the risk of nephrotoxicity. The preferred approach to AUC-guided therapy is to apply model-informed precision dosing (MIPD). However, the adoption in clinical practice has been slow.
Aim
We aimed to develop an intervention, including a standardised MIPD workflow and an implementation plan for vancomycin AUC-guided dosing, in a Swedish tertiary hospital.
Method
The intervention was developed in a framework-guided process. The design phase included stakeholder feedback (nurses, pharmacists, physicians), local data collection and feasibility testing of intervention components with parallel consideration of implementation aspects. The hypothesised relationships between the different components, implementation strategies and the mechanism of action resulting in expected outcomes were represented by a logic model.
Results
The final intervention consisted of a workflow for MIPD, with defined roles and responsibilities, as well as processes for data and information transfer. Details were provided in supportive documents; an instruction on therapeutic drug monitoring (TDM) sampling and documentation for nurses, and a detailed dosing software instruction for MIPD consultants and clinical pharmacists. Activities to facilitate implementation included the development of a local clinical routine for vancomycin dosing, staff training and recurring MIPD rounds.
Conclusion
An intervention for MIPD, with an implementation plan for AUC-guided dosing of vancomycin, was developed for a tertiary hospital setting. The process can be used as guidance for other institutions with similar context wishing to initiate MIPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden.
- Department of Clinical Chemistry and Pharmacology, Uppsala University Hospital, Uppsala, Sweden.
- Department of Medical Sciences, Infection Medicine, Uppsala University, Uppsala, Sweden.
- Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden. elisabet.nielsen@farmaci.uu.se.
Förderung
- VINNOVA
- Vetenskapsrådet
- Uppsala University
Zitieren
APA
Swartling, M., Hamberg, A. K., Furebring, M., Tängdén, T., & Nielsen, E. I. (2025). Model-informed precision dosing of vancomycin in clinical practice: an intervention development study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01822-x
Vancouver
Swartling M, Hamberg AK, Furebring M, Tängdén T, Nielsen EI. Model-informed precision dosing of vancomycin in clinical practice: an intervention development study. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-024-01822-x
BibTeX
@article{Swartling2025,
author = {Swartling, Maria and Hamberg, Anna-Karin and Furebring, Mia and Tängdén, Thomas and Nielsen, Elisabet I},
title = {Model-informed precision dosing of vancomycin in clinical practice: an intervention development study},
journal = {International Journal of Clinical Pharmacy},
year = {2025},
doi = {10.1007/s11096-024-01822-x}
}
EUVIMED